FT US Healthcare & Life Sciences Summit


Transformation Strategies for a Value Driven World

The US healthcare industry is experiencing a period of profound change, from both the political arena and more operationally, new payment and delivery models which are fundamentally reshaping how the industry conducts its business. Traditional boundaries between healthcare and life sciences businesses and professions are being dismantled.

ICON is proud to sponsor the 6th annual Financial Times US Healthcare & Life Sciences Summit which brings together life science companies, their health industry counterparts and emerging new industry entrants to review their key challenges, and the business models and transformation strategies that will be needed to survive and thrive in a changing market.

ICON can offer clients and select third parties a 25% discount on the registration fee. Simply complete the short form to receive your registration discount code.

Some Key Speakers include:

Steve Cutler
Chief Operating Officer, ICON plc

Steve Cutler will assume the role of Chief Executive Officer on 1st March, 2017. He is responsible for leading the company’s global operations, strategic customer alliances and the management of more than 460 clinical development projects from Phase IIb - IV. Steve has over 28 years of pharma and CRO experience.


Ramita Tandon
Executive Vice President, Commercialisation and Outcomes, ICON plc
Ramita has been involved in the drug development industry for over 20 years with a focus on building new opportunities for various clinical research organizations. Ramita’s passion and commitment in the commercial and outcomes domain stems from her belief that the commercial model is ripe for significant change and innovation and will continue to serve as a driving force in the overall healthcare ecosystem.

Jack Bailey
President US Pharmaceuticals, GlaxoSmithKline

Heather Bresch
Chief Executive Officer, Mylan

Dieter Weinand
President and Chairman of the Board, Bayer Pharma AG

Steve Miller
Vice President and Chief Medical Officer, Express Scripts

Why attend?

  • Gain insights into the next stage of reform and how the future of healthcare in the US will unfold.
  • Keep abreast of the next big thing in healthcare-tackling the social determinants of health.
  • Review the diverse strategies leading-edge companies are adopting to manage the cost and improve outcomes of diabetes care.
  • Understand the game-changing implications for payers, providers, and patients of MACRA and the accelerating transition from fee-for-service to value based care.